En español

Buprenorphine Prescribers Treat Below Current Patient Limits

Science Spotlight

September 20, 2016

Doctor is writing a prescription in the Consulting RoomPhoto by ©istock.com/ognianm

A new NIDA-funded study analysis found that the monthly numbers of opioid use disorder patients treated by buprenorphine prescribers were significantly below current limits, suggesting that barriers exist to securing treatment.

Buprenorphine, a medication effective in treating people with opioid use disorders, can be prescribed by addiction specialists or physicians who complete an 8-hour course and obtain a waiver from the U.S. Drug Enforcement Administration. Waivered prescribers are restricted to treating up to 30 patients with an opioid use disorder concurrently; after a year, physicians could request that the limit be increased to 100 patients.

There has been concern that the limits prevent patients from receiving treatment; however this analysis suggests that prescribers are treating fewer patients than even the limits allow. More than 20 percent treated three or fewer patients, and fewer than 10 percent treated more than 75 patients. The median treatment duration (53 days) was lower than expected given clinical recommendations of maintenance treatment for up to 12 months and evidence linking longer treatment to better outcomes.

Using a database of pharmacy retail transactions from more than 80 percent of pharmacies nationwide, the researchers analyzed 3,234 buprenorphine prescribers with 245,015 patients receiving a new prescription of buprenorphine. 

The authors suggest that barriers to treating more patients include insufficient access to more experienced prescribers and substance use treatment counseling options. They recommend options for addressing these barriers, such as web-based or tele-counseling for patients and programs providing mentoring and telephone consultation from more experienced prescribers.

For a copy of the paper, "Physician capacity to treat opioid use disorder with buprenorphine‐assisted treatment," published in the Journal of the American Medical Association, go to http://jama.jamanetwork.com/article.aspx?articleid=2553439.

For information about opioids, go to: https://www.drugabuse.gov/drugs-abuse/opioids.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245. Follow NIDA on Twitter and Facebook.

NIDA Press Office

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases

Mar 2017

Feb 2017

Dec 2016

Nov 2016

Oct 2016

Sep 2016

Aug 2016

Jul 2016

Jun 2016

May 2016

Apr 2016

Mar 2016

Feb 2016

Jan 2016

Dec 2015

Nov 2015

Oct 2015

Sep 2015

Aug 2015

Jul 2015

Jun 2015

May 2015

Apr 2015

Mar 2015

Feb 2015

Jan 2015

Dec 2014

Nov 2014

Oct 2014

Sep 2014

Aug 2014

Jul 2014

Jun 2014

May 2014

Apr 2014

Mar 2014

Feb 2014

Jan 2014

Dec 2013

Nov 2013

Oct 2013

Sep 2013

Aug 2013

Jul 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Jan 2011

Dec 2010

Nov 2010

Sep 2010

Aug 2010

Jul 2010

May 2010

Apr 2010

Mar 2010

Jan 2010

Get this Publication

    Cite this article

    APA style citation

    NIDA (). Buprenorphine Prescribers Treat Below Current Patient Limits. Retrieved , from https://www.drugabuse.gov/news-events/news-releases/2016/09/buprenorphine-prescribers-treat-below-current-patient-limits

    press ctrl+c to copy
    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science